查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1403415

到 2030 年关节止痛注射市场预测：按关节类型、注射类型、配销通路、最终用户和地区进行的全球分析

Joint Pain Injections Market Forecasts to 2030 - Global Analysis By Joint Type (Shoulder and Elbow, Facet Joints of the Spine, Knee and Ankle, Hip Joint and Other Joint Types), Injection Type, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球关节止痛注射市场规模为 52 亿美元，预计到 2030 年将达到 107 亿美元，预测期内复合年增长率为 10.6%。

直接注射到关节用于治疗关节疼痛，减少肿胀和发炎。在老年人中，关节不适通常是由原有疾病引起的。关节炎是一种广泛传播的疾病，主要影响脊椎的髋关节、膝关节、肘关节、肩关节和小关节。关节炎会导致关节发炎和不舒服。

根据英国关节炎研究中心的报告《2018年肌肉骨骼健康状况》，估计英国有1,780万人患有肌肉骨骼疾病，约占全国总人口的28.9%。

关节炎增加

关节炎是全世界成年人残疾最常见的原因。例如，皮质类固醇或透明质酸注射可以透过润滑关节和减少发炎来显着减轻疼痛并缓解僵硬和不适。透过仔细地将药物给药到疼痛或发炎区域，注射针对受影响的关节，提高疗效并最大限度地减少全身副作用。在此背景下，市场规模不断扩大。

副作用和过敏

关节止痛注射患者所经历的副作用和过敏是市场扩张的主要障碍。一些因关节疼痛而接受注射的患者的软骨和神经受到损伤，这影响了这些医疗设备的生产和销售。此外，产业扩张的最大障碍是患者使用关节止痛注射剂导致的皮肤变色和感染疾病。

关节相关疾病的盛行率增加

市场驱动因素之一是关节相关疾病的盛行率不断增加。骨关节炎和类风湿性关节炎等疾病的发生率不断增加，对有效的疼痛管理解决方案（包括关节疼痛注射）产生了巨大的需求。人口高龄化、久坐生活方式和运动相关伤害的增加进一步促进了市场成长。

缺乏知识

一般人从未听过注射治疗关节疼痛。富含血小板的血浆、皮质类固醇和透明质酸注射用于缓解关节不适。使用这些注射需要大量的专业知识和培训。医生和其他医疗专业人员经常因关节不适而给患者註射。专业人员将获得完成此任务所需的工具和培训。然而，由于政府缺乏鼓励注射治疗关节疼痛的措施，市场成长有限。

COVID-19 的影响：

事实证明，COVID-19 大流行是一场独特的全球公共卫生灾难，几乎影响所有企业，其影响将影响预测期内每个行业的成长。预计会产生影响。在全球范围内，供应链途径、采购模式、客户需求和行为以及政府关键措施正在发生一些变化。疫情改变了人们的生活方式、用药方式以及其他与健康相关的习惯。

透明质酸注射细分市场预计将成为预测期内最大的细分市场

预计透明质酸注射领域在预测期内将是最大的。已经尝试过对乙酰胺酚和其他阿片类药物等无效治疗的患者正在接受透明质酸注射治疗，以治疗与骨关节炎相关的膝盖不适。透明质酸注射作为一种非手术治疗选择正在逐渐普及，特别是考虑到医生通常不愿意常规进行关节内皮质类固醇注射。

预计医院药房领域在预测期内的复合年增长率最高。

预计医院药房领域在预测期内的复合年增长率最高。除了有能力的药剂师外，医院药局还经常聘请接受肠外药物给药特殊培训的医疗专业人员，这可以确保正确的技术并减少出现问题的机会。患者可以获得更广泛的疼痛管理选择，包括根据其特定需求量身定制的不同类型的注射和联合治疗。

比最大的地区

由于肌肉骨骼疾病的高盛行率和老年人口的增加，预计北美在预测期内将占据最大的市场占有率。这是由于该地区市场参与企业的高度集中、该地区行业参与者的强大影响力、医疗保健基础设施的改善以及公众和行业对现有技术的兴趣。这是由多种因素造成的，包括相关人员的知识。该地区的市场不断扩大，部分原因在于最尖端科技的高采用率。

复合年增长率最高的地区：

预计亚太地区在预测期内将维持最高的复合年增长率。骨关节炎盛行率的上升以及区域竞争对手进入 Visco补充品产品正在推动每个国家市场的成长。此外，有关尖端关节疼痛治疗的知识的普及为患者接受这些治疗方法创造了理想的环境。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 介绍
  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球关节止痛注射市场：依关节类型

  • 肩膀和肘部
  • 脊椎的椎间关节
  • 膝盖和脚踝
  • 髋关节
  • 其他接头类型

第六章全球关节止痛注射市场：按註射类型

  • 白细胞介素抑制剂
  • 玻尿酸注射
  • 类固醇关节注射
  • 富血小板血浆（PRP）注射
  • 胎盘组织基质 (PTM) 注射
  • 其他注射类型

第七章全球关节止痛注射市场：依配销通路

  • 零售药房
  • 医院药房
  • 网路药房

第八章全球关节止痛注射市场：依最终用户分类

  • 医院
  • 诊所
  • 其他最终用户

第九章全球关节止痛注射市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司简介

  • Anika Therapeutics, Inc.
  • Sanofi aventis LLC
  • Ferring BV
  • Zimmer Biomet
  • Bioventus LLC
  • Allergen Plc.
  • Pfizer Inc.
  • Chugai Pharmaceutical Co. Ltd
  • SEIKAGAKU Corporation
  • Ferring BV
  • Pacira Biosciences
  • OrthogenRx
  • Pfizer
  • Lifecore Biomedical
  • Wright Medical Group
  • AbbVie
  • Stryker
Product Code: SMRC24640

According to Stratistics MRC, the Global Joint Pain Injections Market is accounted for $5.2 billion in 2023 and is expected to reach $10.7 billion by 2030 growing at a CAGR of 10.6% during the forecast period. Direct injections into the joints are used to treat joint pain in order to reduce swelling and inflammation. In the elderly population, joint discomfort is typically brought on by pre-existing conditions. The widespread ailment known as arthritis mostly affects the hip, knee, elbow, shoulder, and facet joints of the spine. It causes inflammation in the joints and makes them uncomfortable.

According to the Arthritis Research UK report, "The State of Musculoskeletal Health 2018", it is estimated that 17.8 million people suffer with a musculoskeletal condition in the UK which is around 28.9% of the total population of the country.

Market Dynamics:

Driver:

Increased occurrence of arthritis

The most frequent cause of adult disability worldwide is arthritis. Corticosteroids and hyaluronic acid injections, for example, can significantly reduce pain by lubricating the joints and decreasing inflammation, which relieves stiffness and discomfort. By carefully administering medicine to the region of pain or inflammation, injections target the afflicted joint, increasing efficacy and minimizing systemic adverse effects. The market is expanding as a result of these causes.

Restraint:

Side effects and allergies

Joint pain injection side effects and allergies that patients experienced have turned out to be a significant barrier to the market's expansion. Some patients who had joint pain injections had damage to their cartilage and nerves, which has had an impact on the manufacturing and marketing of these medical devices. Furthermore, the largest obstacle to the industry's expansion has been shown to be skin discoloration and infections that result from patients using joint pain inoculations.

Opportunity:

Growing prevalence of joint-related disorders

One driver of the market is the growing prevalence of joint-related disorders. The increasing incidence of conditions such as osteoarthritis and rheumatoid arthritis has created a substantial demand for effective pain management solutions, including joint pain injections. The rising aging population, sedentary lifestyles, and sports-related injuries further contribute to the market growth.

Threat:

Lack of knowledge

The average population has never heard about joint pain injections. Platelet-rich plasma, corticosteroids, and hyaluronic acid injections are used to relieve joint discomfort. To utilize these injections, one must possess a great deal of expertise and training. Physicians and other medical professionals frequently inject people for joint discomfort. The tools and training needed for professionals to do this are supplied. The lack of government measures to encourage joint pain injections, however, limits the market's growth.

COVID-19 Impact:

The COVID-19 pandemic has turned out to be an unparalleled worldwide public health disaster that has impacted practically every business, and its repercussions are anticipated to have an impact on every industry's growth over the projection period. Globally, there have been several shifts in supply chain rerouting, purchasing patterns, customer demand and behavior, and major government efforts. The epidemic has altered people's lifestyles, drug usage patterns, and other health-related habits.

The hyaluronic acid injections segment is expected to be the largest during the forecast period

The hyaluronic acid injections segment is expected to be the largest during the forecast period. Patients who have already tried ineffective treatments like acetaminophen and other opioids are treated with hyaluronic acid injections for knee discomfort associated with osteoarthritis. Injections of hyaluronic acid have grown in favor as a non-surgical treatment option, especially considering that physicians are generally reluctant to administer intraarticular corticosteroid injections on a regular basis.

The hospital pharmacies segment is expected to have the highest CAGR during the forecast period

The hospital pharmacies segment is expected to have the highest CAGR during the forecast period. Hospital pharmacies frequently employ medical professionals with specific training in injectable administration in addition to competent pharmacists, assuring correct technique and lowering the chance of problems. Patients have access to a wider range of pain management options, including different types of injections or combination therapies tailored to their specific needs.

Region with largest share:

North America is projected to hold the largest market share during the forecast period due to the high prevalence of musculoskeletal disorders, growing geriatric population. This is ascribed to a number of factors, including the large concentration of market participants in the area, the robust presence of industry companies in the area, improved healthcare infrastructure, and public and industry stakeholder knowledge of available technology. The market in this area is expanding due in part to a high rate of adoption of cutting-edge technology.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period. The rising incidence of osteoarthritis and the entry of viscosupplement products by regional competitors are propelling the growth of the respective markets in each country. Furthermore, ideal circumstances for the patient population's acceptance of these therapies are created by the growing knowledge of cutting-edge joint pain treatments in the area.

Key players in the market:

Some of the key players in Joint Pain Injections market include Anika Therapeutics, Inc., Sanofi aventis LLC, Ferring B.V., Zimmer Biomet, Bioventus LLC, Allergen Plc., Pfizer Inc., Chugai Pharmaceutical Co. Ltd, SEIKAGAKU Corporation, Ferring B.V., Pacira Biosciences, OrthogenRx, Pfizer, Lifecore Biomedical, Wright Medical Group, AbbVie and Stryker.

Key Developments:

In January 2023, AbbVie received the United States Food and Drug Administration (FDA) approval for SKYRIZI (risankizumab-rzaa) for the treatment of adults with active psoriatic arthritis (PsA), which can be administered with a single injection four times a year.

In March 2022, Sanofi collaborated with IGM Biosciences Inc. to develop, manufacture, and introduce potential therapeutics in the fields of immunology and inflammation.

Joint Types Covered:

  • Shoulder and Elbow
  • Facet Joints of the Spine
  • Knee and Ankle
  • Hip Joint
  • Other Joint Types

Injection Types Covered:

  • Interleukin Inhibitors
  • Hyaluronic Acid Injections
  • Steroid Joint Injections
  • Platelet-rich Plasma (PRP) Injections
  • Placental Tissue Matrix (PTM) Injections
  • Other Injection Types

Distribution Channels Covered:

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

End Users Covered:

  • Hospitals
  • Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introducton
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Joint Pain Injections Market, By Joint Type

  • 5.1 Introduction
  • 5.2 Shoulder and Elbow
  • 5.3 Facet Joints of the Spine
  • 5.4 Knee and Ankle
  • 5.5 Hip Joint
  • 5.6 Other Joint Types

6 Global Joint Pain Injections Market, By Injection Type

  • 6.1 Introduction
  • 6.2 Interleukin Inhibitors
  • 6.3 Hyaluronic Acid Injections
  • 6.4 Steroid Joint Injections
  • 6.5 Platelet-rich Plasma (PRP) Injections
  • 6.6 Placental Tissue Matrix (PTM) Injections
  • 6.7 Other Injection Types

7 Global Joint Pain Injections Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Retail Pharmacies
  • 7.3 Hospital Pharmacies
  • 7.4 Online Pharmacies

8 Global Joint Pain Injections Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Clinics
  • 8.4 Other End Users

9 Global Joint Pain Injections Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Anika Therapeutics, Inc.
  • 11.2 Sanofi aventis LLC
  • 11.3 Ferring B.V.
  • 11.4 Zimmer Biomet
  • 11.5 Bioventus LLC
  • 11.6 Allergen Plc.
  • 11.7 Pfizer Inc.
  • 11.8 Chugai Pharmaceutical Co. Ltd
  • 11.9 SEIKAGAKU Corporation
  • 11.10 Ferring B.V.
  • 11.11 Pacira Biosciences
  • 11.12 OrthogenRx
  • 11.13 Pfizer
  • 11.14 Lifecore Biomedical
  • 11.15 Wright Medical Group
  • 11.16 AbbVie
  • 11.17 Stryker

List of Tables

  • Table 1 Global Joint Pain Injections Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Joint Pain Injections Market Outlook, By Joint Type (2021-2030) ($MN)
  • Table 3 Global Joint Pain Injections Market Outlook, By Shoulder and Elbow (2021-2030) ($MN)
  • Table 4 Global Joint Pain Injections Market Outlook, By Facet Joints of the Spine (2021-2030) ($MN)
  • Table 5 Global Joint Pain Injections Market Outlook, By Knee and Ankle (2021-2030) ($MN)
  • Table 6 Global Joint Pain Injections Market Outlook, By Hip Joint (2021-2030) ($MN)
  • Table 7 Global Joint Pain Injections Market Outlook, By Other Joint Types (2021-2030) ($MN)
  • Table 8 Global Joint Pain Injections Market Outlook, By Injection Type (2021-2030) ($MN)
  • Table 9 Global Joint Pain Injections Market Outlook, By Interleukin Inhibitors (2021-2030) ($MN)
  • Table 10 Global Joint Pain Injections Market Outlook, By Hyaluronic Acid Injections (2021-2030) ($MN)
  • Table 11 Global Joint Pain Injections Market Outlook, By Steroid Joint Injections (2021-2030) ($MN)
  • Table 12 Global Joint Pain Injections Market Outlook, By Platelet-rich Plasma (PRP) Injections (2021-2030) ($MN)
  • Table 13 Global Joint Pain Injections Market Outlook, By Placental Tissue Matrix (PTM) Injections (2021-2030) ($MN)
  • Table 14 Global Joint Pain Injections Market Outlook, By Other Injection Types (2021-2030) ($MN)
  • Table 15 Global Joint Pain Injections Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 16 Global Joint Pain Injections Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 17 Global Joint Pain Injections Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 18 Global Joint Pain Injections Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 19 Global Joint Pain Injections Market Outlook, By End User (2021-2030) ($MN)
  • Table 20 Global Joint Pain Injections Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 21 Global Joint Pain Injections Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 22 Global Joint Pain Injections Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 23 North America Joint Pain Injections Market Outlook, By Country (2021-2030) ($MN)
  • Table 24 North America Joint Pain Injections Market Outlook, By Joint Type (2021-2030) ($MN)
  • Table 25 North America Joint Pain Injections Market Outlook, By Shoulder and Elbow (2021-2030) ($MN)
  • Table 26 North America Joint Pain Injections Market Outlook, By Facet Joints of the Spine (2021-2030) ($MN)
  • Table 27 North America Joint Pain Injections Market Outlook, By Knee and Ankle (2021-2030) ($MN)
  • Table 28 North America Joint Pain Injections Market Outlook, By Hip Joint (2021-2030) ($MN)
  • Table 29 North America Joint Pain Injections Market Outlook, By Other Joint Types (2021-2030) ($MN)
  • Table 30 North America Joint Pain Injections Market Outlook, By Injection Type (2021-2030) ($MN)
  • Table 31 North America Joint Pain Injections Market Outlook, By Interleukin Inhibitors (2021-2030) ($MN)
  • Table 32 North America Joint Pain Injections Market Outlook, By Hyaluronic Acid Injections (2021-2030) ($MN)
  • Table 33 North America Joint Pain Injections Market Outlook, By Steroid Joint Injections (2021-2030) ($MN)
  • Table 34 North America Joint Pain Injections Market Outlook, By Platelet-rich Plasma (PRP) Injections (2021-2030) ($MN)
  • Table 35 North America Joint Pain Injections Market Outlook, By Placental Tissue Matrix (PTM) Injections (2021-2030) ($MN)
  • Table 36 North America Joint Pain Injections Market Outlook, By Other Injection Types (2021-2030) ($MN)
  • Table 37 North America Joint Pain Injections Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 38 North America Joint Pain Injections Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 39 North America Joint Pain Injections Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 40 North America Joint Pain Injections Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 41 North America Joint Pain Injections Market Outlook, By End User (2021-2030) ($MN)
  • Table 42 North America Joint Pain Injections Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 43 North America Joint Pain Injections Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 44 North America Joint Pain Injections Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 45 Europe Joint Pain Injections Market Outlook, By Country (2021-2030) ($MN)
  • Table 46 Europe Joint Pain Injections Market Outlook, By Joint Type (2021-2030) ($MN)
  • Table 47 Europe Joint Pain Injections Market Outlook, By Shoulder and Elbow (2021-2030) ($MN)
  • Table 48 Europe Joint Pain Injections Market Outlook, By Facet Joints of the Spine (2021-2030) ($MN)
  • Table 49 Europe Joint Pain Injections Market Outlook, By Knee and Ankle (2021-2030) ($MN)
  • Table 50 Europe Joint Pain Injections Market Outlook, By Hip Joint (2021-2030) ($MN)
  • Table 51 Europe Joint Pain Injections Market Outlook, By Other Joint Types (2021-2030) ($MN)
  • Table 52 Europe Joint Pain Injections Market Outlook, By Injection Type (2021-2030) ($MN)
  • Table 53 Europe Joint Pain Injections Market Outlook, By Interleukin Inhibitors (2021-2030) ($MN)
  • Table 54 Europe Joint Pain Injections Market Outlook, By Hyaluronic Acid Injections (2021-2030) ($MN)
  • Table 55 Europe Joint Pain Injections Market Outlook, By Steroid Joint Injections (2021-2030) ($MN)
  • Table 56 Europe Joint Pain Injections Market Outlook, By Platelet-rich Plasma (PRP) Injections (2021-2030) ($MN)
  • Table 57 Europe Joint Pain Injections Market Outlook, By Placental Tissue Matrix (PTM) Injections (2021-2030) ($MN)
  • Table 58 Europe Joint Pain Injections Market Outlook, By Other Injection Types (2021-2030) ($MN)
  • Table 59 Europe Joint Pain Injections Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 60 Europe Joint Pain Injections Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 61 Europe Joint Pain Injections Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 62 Europe Joint Pain Injections Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 63 Europe Joint Pain Injections Market Outlook, By End User (2021-2030) ($MN)
  • Table 64 Europe Joint Pain Injections Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 65 Europe Joint Pain Injections Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 66 Europe Joint Pain Injections Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 67 Asia Pacific Joint Pain Injections Market Outlook, By Country (2021-2030) ($MN)
  • Table 68 Asia Pacific Joint Pain Injections Market Outlook, By Joint Type (2021-2030) ($MN)
  • Table 69 Asia Pacific Joint Pain Injections Market Outlook, By Shoulder and Elbow (2021-2030) ($MN)
  • Table 70 Asia Pacific Joint Pain Injections Market Outlook, By Facet Joints of the Spine (2021-2030) ($MN)
  • Table 71 Asia Pacific Joint Pain Injections Market Outlook, By Knee and Ankle (2021-2030) ($MN)
  • Table 72 Asia Pacific Joint Pain Injections Market Outlook, By Hip Joint (2021-2030) ($MN)
  • Table 73 Asia Pacific Joint Pain Injections Market Outlook, By Other Joint Types (2021-2030) ($MN)
  • Table 74 Asia Pacific Joint Pain Injections Market Outlook, By Injection Type (2021-2030) ($MN)
  • Table 75 Asia Pacific Joint Pain Injections Market Outlook, By Interleukin Inhibitors (2021-2030) ($MN)
  • Table 76 Asia Pacific Joint Pain Injections Market Outlook, By Hyaluronic Acid Injections (2021-2030) ($MN)
  • Table 77 Asia Pacific Joint Pain Injections Market Outlook, By Steroid Joint Injections (2021-2030) ($MN)
  • Table 78 Asia Pacific Joint Pain Injections Market Outlook, By Platelet-rich Plasma (PRP) Injections (2021-2030) ($MN)
  • Table 79 Asia Pacific Joint Pain Injections Market Outlook, By Placental Tissue Matrix (PTM) Injections (2021-2030) ($MN)
  • Table 80 Asia Pacific Joint Pain Injections Market Outlook, By Other Injection Types (2021-2030) ($MN)
  • Table 81 Asia Pacific Joint Pain Injections Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 82 Asia Pacific Joint Pain Injections Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 83 Asia Pacific Joint Pain Injections Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 84 Asia Pacific Joint Pain Injections Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 85 Asia Pacific Joint Pain Injections Market Outlook, By End User (2021-2030) ($MN)
  • Table 86 Asia Pacific Joint Pain Injections Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 87 Asia Pacific Joint Pain Injections Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 88 Asia Pacific Joint Pain Injections Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 89 South America Joint Pain Injections Market Outlook, By Country (2021-2030) ($MN)
  • Table 90 South America Joint Pain Injections Market Outlook, By Joint Type (2021-2030) ($MN)
  • Table 91 South America Joint Pain Injections Market Outlook, By Shoulder and Elbow (2021-2030) ($MN)
  • Table 92 South America Joint Pain Injections Market Outlook, By Facet Joints of the Spine (2021-2030) ($MN)
  • Table 93 South America Joint Pain Injections Market Outlook, By Knee and Ankle (2021-2030) ($MN)
  • Table 94 South America Joint Pain Injections Market Outlook, By Hip Joint (2021-2030) ($MN)
  • Table 95 South America Joint Pain Injections Market Outlook, By Other Joint Types (2021-2030) ($MN)
  • Table 96 South America Joint Pain Injections Market Outlook, By Injection Type (2021-2030) ($MN)
  • Table 97 South America Joint Pain Injections Market Outlook, By Interleukin Inhibitors (2021-2030) ($MN)
  • Table 98 South America Joint Pain Injections Market Outlook, By Hyaluronic Acid Injections (2021-2030) ($MN)
  • Table 99 South America Joint Pain Injections Market Outlook, By Steroid Joint Injections (2021-2030) ($MN)
  • Table 100 South America Joint Pain Injections Market Outlook, By Platelet-rich Plasma (PRP) Injections (2021-2030) ($MN)
  • Table 101 South America Joint Pain Injections Market Outlook, By Placental Tissue Matrix (PTM) Injections (2021-2030) ($MN)
  • Table 102 South America Joint Pain Injections Market Outlook, By Other Injection Types (2021-2030) ($MN)
  • Table 103 South America Joint Pain Injections Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 104 South America Joint Pain Injections Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 105 South America Joint Pain Injections Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 106 South America Joint Pain Injections Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 107 South America Joint Pain Injections Market Outlook, By End User (2021-2030) ($MN)
  • Table 108 South America Joint Pain Injections Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 109 South America Joint Pain Injections Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 110 South America Joint Pain Injections Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 111 Middle East & Africa Joint Pain Injections Market Outlook, By Country (2021-2030) ($MN)
  • Table 112 Middle East & Africa Joint Pain Injections Market Outlook, By Joint Type (2021-2030) ($MN)
  • Table 113 Middle East & Africa Joint Pain Injections Market Outlook, By Shoulder and Elbow (2021-2030) ($MN)
  • Table 114 Middle East & Africa Joint Pain Injections Market Outlook, By Facet Joints of the Spine (2021-2030) ($MN)
  • Table 115 Middle East & Africa Joint Pain Injections Market Outlook, By Knee and Ankle (2021-2030) ($MN)
  • Table 116 Middle East & Africa Joint Pain Injections Market Outlook, By Hip Joint (2021-2030) ($MN)
  • Table 117 Middle East & Africa Joint Pain Injections Market Outlook, By Other Joint Types (2021-2030) ($MN)
  • Table 118 Middle East & Africa Joint Pain Injections Market Outlook, By Injection Type (2021-2030) ($MN)
  • Table 119 Middle East & Africa Joint Pain Injections Market Outlook, By Interleukin Inhibitors (2021-2030) ($MN)
  • Table 120 Middle East & Africa Joint Pain Injections Market Outlook, By Hyaluronic Acid Injections (2021-2030) ($MN)
  • Table 121 Middle East & Africa Joint Pain Injections Market Outlook, By Steroid Joint Injections (2021-2030) ($MN)
  • Table 122 Middle East & Africa Joint Pain Injections Market Outlook, By Platelet-rich Plasma (PRP) Injections (2021-2030) ($MN)
  • Table 123 Middle East & Africa Joint Pain Injections Market Outlook, By Placental Tissue Matrix (PTM) Injections (2021-2030) ($MN)
  • Table 124 Middle East & Africa Joint Pain Injections Market Outlook, By Other Injection Types (2021-2030) ($MN)
  • Table 125 Middle East & Africa Joint Pain Injections Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 126 Middle East & Africa Joint Pain Injections Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 127 Middle East & Africa Joint Pain Injections Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 128 Middle East & Africa Joint Pain Injections Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 129 Middle East & Africa Joint Pain Injections Market Outlook, By End User (2021-2030) ($MN)
  • Table 130 Middle East & Africa Joint Pain Injections Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 131 Middle East & Africa Joint Pain Injections Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 132 Middle East & Africa Joint Pain Injections Market Outlook, By Other End Users (2021-2030) ($MN)